Top Markets
#1 Helium Helium +83.36%
#2 Seeker Seeker +52.14%
#3 Pons Pons +36.63%
#4 UnifAI Network UnifAI Network +29.95%
#5 TENDIES TENDIES +27.32%
#6 Tensor Tensor +23.80%
#7 Zylo Ecosystem Zylo Ecosystem +23.78%
#8 Bounce Bounce +17.72%
#9 pipedog pipedog +16.96%
#10 Songbird Songbird +15.11%
Coin of the day
Helium Helium
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Senores Pharmaceuticals Ltd. Senores Pharmaceuticals Ltd.

Senores Pharmaceuticals Ltd.

SENORES
Classifica tra le azioni #11030
Established in 2017 and headquartered in Ahmedabad, India, Senores... Established in 2017 and headquartered in Ahmedabad, India, Senores Pharmaceuticals Ltd. is actively involved in the development, manufacturing, and global commercialization of pharmaceutical and related products. Its extensive portfolio reaches markets across India, the United States, the United Kingdom, Canada, and other international territories. The company specializes in a diverse array of therapeutic solutions, encompassing analgesics/antipyretics, anesthetics, antibacterials, antivirals, antifungals, antioxidants, antineoplastics, blood-related therapies, cardiovascular and neurological medications, antacids, and vitamin and mineral supplements. Additionally, Senores offers a selection of generic drugs targeting pain, inflammation, fever, diabetes, malaria, and urinary tract conditions, as well as neutral supplements. Complementing its product offerings, the firm also provides management and consultancy services.
Prezzo delle azioni
$16.36
Ultima sincronizzazione: 2026-08-28
Capitalizzazione di mercato
$753.27M
Variazione (1 giorno)
0.51%
Variazione (1 anno)
108.95%
Paese
IN
Scambia Senores Pharmaceuticals Ltd. (SENORES)

Categoria

Healthcare
Ricavi di Senores Pharmaceuticals Ltd. (SENORES)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Senores Pharmaceuticals Ltd., i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Senores Pharmaceuticals Ltd. da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $79.67B -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $97.93B -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $64.39B -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $77.52B -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $66.40B -
US